MET Signaling Pathways, Resistance Mechanisms, and Opportunities for Target Therapies
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.extent
item.page.accessRights
item.page.other
item.page.references
Abstract
The MET gene, known as MET proto-oncogene receptor tyrosine kinase, was first identified to induce tumor cell migration, invasion, and proliferation/survival through canonical RAS-CDC42-PAK-Rho kinase...
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
Rivas, S.; Marín, A.; Samtani, S.; González-Feliú, E.; Armisén, R. MET Signaling Pathways, Resistance Mechanisms, and Opportunities for Target Therapies. Int. J. Mol. Sci. 2022, 23, 13898. https://doi.org/10.3390/ ijms232213898
Keywords
item.page.dc.rights
item.page.dc.rights.url
Estadísticas de uso
1 0,8 0,5 0,3 0
Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026Marzo 2026